Leina Ma
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
Papers in
-
- Ubiquitin and proteasome pathways 10
- Protein Degradation and Inhibitors 5
- Glycosylation and Glycoproteins Research 4
- ATP Synthase and ATPases Research 4
-
- Cancer, Hypoxia, and Metabolism 7
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 4
- Co-authors
- Cheng Qian (7 shared papers)Junjie Shen (6 shared papers)Jia Liu (10 shared papers)Zhi Yang (6 shared papers)Yanmin Xu (4 shared papers)Juanjuan Shan (4 shared papers)Wenyi Wei (2 shared papers)You‐Hong Cui (4 shared papers)
- Journals
- Cancer Letters (3 papers)Frontiers in Immunology (3 papers)Oncotarget (2 papers)Hepatology (2 papers)Theranostics (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Leina Ma
52 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 711
- Molecular Biology 1.5k
- Oncology 517
- Hepatology 84
- Immunology 173
Countries citing papers authored by Leina Ma
This map shows the geographic impact of Leina Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leina Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leina Ma more than expected).
Fields of papers citing papers by Leina Ma
This network shows the impact of papers produced by Leina Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leina Ma. The network helps show where Leina Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Leina Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 263 | |
| 2 | 2020 | 232 | |
| 3 | 2011 | 176 | |
| 4 | 2015 | 135 | |
| 5 | 2010 | 128 | |
| 6 | 2017 | 121 | |
| 7 | 2023 | 78 | |
| 8 | 2014 | 74 | |
| 9 | 2009 | 73 | |
| 10 | 2013 | 70 | |
| 11 | 2014 | 59 | |
| 12 | 2014 | 58 | |
| 13 | 2012 | 56 | |
| 14 | 2015 | 53 | |
| 15 | 2014 | 53 | |
| 16 | 2018 | 51 | |
| 17 | 2022 | 46 | |
| 18 | 2016 | 46 | |
| 19 | 2015 | 44 | |
| 20 | 2016 | 43 |
About Leina Ma
Leina Ma is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 55 papers that have together received 2.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Cancer, Hypoxia, and Metabolism (7 papers), Protein Degradation and Inhibitors (5 papers), MicroRNA in disease regulation (5 papers), Glycosylation and Glycoproteins Research (4 papers), ATP Synthase and ATPases Research (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (711 citations), Molecular Biology (1.5k citations), Oncology (517 citations), Hepatology (84 citations) and Immunology (173 citations). Leina Ma has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Cheng Qian, Junjie Shen, Jia Liu, Zhi Yang, Yanmin Xu, Juanjuan Shan, Wenyi Wei, You‐Hong Cui, Ping Bie and Qian Lin. Their work appears in journals such as Cancer Letters, Frontiers in Immunology, Oncotarget, Hepatology and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.